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THE OCCURRENCE AND NATURE OF ARYLSULFATASES IN
PARAKERATOSES *
C. SACHS AND 0. BRAUN-FALCO
The previous work on the occurrence of the
arylsulfatases in skin (1) was done before the
complex nature of the arylsulfatases was appreci-
ated (10). In addition, there is no information on
the occurrence of sulfatases in various parakera-
totic lesions.
Because there appears to be an increase of
activity in other hydrolytic enzymes in disease
processes (1) this following work was under-
taken to attempt to determine the occurrence
and nature of the arylsulfatases in normal and
in diseased epidermis.
MATERIALS AND METHODS
Collection of Tissues
Fresh rat epidermis was obtained from Sprague
Dawley albino strain by the stretch method (3)
and treated as described below.
Normal human epidermis was obtained by
stretch method from surgical specimens from
abdominal skin. Specimens from callus were ob-
tained by an electrical scraper.
Scales were collected by scraping the involved
areas of skin with a scalpel. The scales so obtained
were either utilized immediately or stored in the
deep freeze (—15° C) prior to use.
Preparation of acetone powder
The scales or tissue were homogenized in
acetone at —15° C in an Ultrahomogenizer
(Buhler) for 10 minutes. The homogenate was
filtered, extracted for a further 15 minutes with
acetone at —15° C filtered and the powder dried
and stored at —15° C. This showed no loss of
activity over 2 weeks.
Preparation of butanol powder (4)
The scales or tissue were homogenized in
n-butanol at —20° C (50 ml/gm) and then ex-
tracted for 20 minutes and filtered. The powder
was then extracted once more with butanol at
—20° C and then twice with acetone each for 10
minute periods. The powder was dried and stored
as before.
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Rat epidermal preparation
The epidermis obtained was immediately
homogenized in 0.5 M acetate buffer at pH 4.9 at
0 for 10 minutes and the whole homogenate
utilized.
Calibration Curve (Graph 1)
This was obtained by adding 1 ml solution
containing a known quantity of nitroeateehol
sulfate to phosphotungstie acid (3.0 ml) and
pipetting 2.0 ml of this into 5.0 ml 2.5 N NaOH
and reading optical density at 525 mp in a Zeiss
speetrophotometer PNQ II.
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Assay Procedure
Routine assays were carried out by weighing
out between 10—15 mgm of the acetone powder
into a small homogenizer tube fitted with a loose
fitting ground glass pestle. The powder was
suspended in 1.0 ml of a solution of 0.006 M nitro-
eateehol sulfate in 5 M acetate buffer adjusted to
pH 4.9. This was incubated at 37° C for 60 minutes
with frequent resuspension and 3 ml of 2.5%
phosphotungstie acid in 0.1 N HCI added. The
protein was centrifuged down and 2.0 ml of the
supernatant was pipetted into 5.0 ml 2.5 N NaOR.
The color developed was read in the Zeiss speetro-
photometer at 525 mp. Controls were run with
immediate phosphotungstie acid addition.
Butanol powder samples were assayed in the
same way. Rat epidermis was assayed by incu-
bating 0.4 ml homogenate with 0.6 ml 0.01 M
nitrocateehol sulfate in 0.5 M acetate buffer at
pH 4.9; color development and estimation being
as above. A similar method was used for human
epidermis.
Solubilization of Enzyme
The enzyme could not be obtained in solution
by buffer or distilled water extraction of either
scales or acetone powder. However butanol pre-
treatment or incubation of the acetone powder
with crude bacterial lipase for 2 hrs followed by
extraction with distilled water or buffer for 12
hrs at 0° C/and eentrifugation at 35,000 g for 25
minutes resulted in a clear supernatant showing
enzyme activity. The supernatant was dialyzed
against 6 changes of distilled water for 24 hrs at
0° C/and the turbid solution centrifuged and the
supernatant stored at —15° C.
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GRAPH 1. Calibration curve: 1 ml nitrocatechol
pipetted into 5 ml 2.5 N NaOH and color read.
0.4 ml of this solution was assayed with 0.6 ml
0.01 M nitrocatechol sulfate in 0.5 M acetate
buffer at pH 4.0 or at given pH.
Nitrogen Estimations
These were kindly performed by Mrs. Holistein
using the micro Kjehldahl method.
Synthesis of Substrate
This was carried out according to Roy (5).
RESULTS
1. Assay Procedure Results
The assay of a preparation of crude sulfatase
is susceptible to several errors. The probable
mixture of sulfatases presents results in enzymes
of varying activity towards a given substrate
concentration nt a given pH, each of the known
sulfatases having a different substrate and pH
optimum. Also the nitroeatechol produced may
be metabolized in crude preparations, or absorbed
on protein and precipitated from solution by
phosphotungstie acid. Further assay in an in-
soluble form will lead to inaccuracies due to
settling down of suspension, non-uniformity of
into 3 ml phosphotungstic acid and 2 ml of this
suspension, lack of access of substrate to enzyme
and presence of natural inhibitors such as phos-
phate (6).
Most of these errors are unavoidable if total
sulfatase activity is to be assayed primarily
because the major quantity of the enzymic
activity could not be obtained in solution, and
further attempts at treatment resulted in in-
creasing loss of enzyme activity. However since
all the above inaccuracies will minimize sulfatase
activity, and the results showed greatly enhanced
level in parakeratoses, it was felt that the method
was acceptable for the purpose of comparative
assay of scaling lesions.
A comparison was made between assay of the
acetone powder and of the butanol powder and
from the graph 2 it can be seen that although the
linearity of the butanol powder method is better
yet the activity of the butanol powder is lower
at low powder concentration suggesting that the
butanol method results in loss of some enzyme
activity. This further implies that in all proba-
bility some activity is lost in acetone prepara-
tions, this being another source of error mini-
mizing sulfatase levels found.
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2. Solubilization
Butanol treatment or incubation with lipase
followed by high speed eentrifugation resulted in
some of the enzyme passing into solution, the
activity of the solution increasing after dialysis.
Approximately 10% of the enzyme was found to
be solubilized in this way, but the remainder was
found to be resistant to further lipase or butanol
treatment. Pepsin treatment resulted in destruc-
tion of enzyme activity. Thus there are probably
at least two forms of bound enzyme, one of
which is probably a lipoprotein.
In an attempt to differentiate between butanol
residue and solubilized enzyme, p11-curves were
studied and these showed that no distinct dif-
ference existed, the results obtained being similar
to p11-curves obtained on dilution of active
solutions of sulfatase A. The p11 optimum found
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GRAPH 2. Milligram powder in 1 ml 0.006 M nitrocatechol sulfate in 0.5 M acetate buffer pH 4.9 incu-
bated at 37° for 1 hour.
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GRAPH 3. (a) 0.4 ml enzyme solution and (b) butanol powder suspension from scales and 0.6 ml 0.01
M nitrocatechol sulfate solution in 0.5 M acetate buffer—pH measured with glass electrode—and incu-
bated for 1 hr. color developed in the usual way.
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GRAPH 4. 10 ml 0.008 nitrocatechol sulfate at pH 4.9 in 0.5 M acetate buffer and 2.0 enzyme solution
or powder suspension incubated at 37°C with shaking and 1.0 ml samples pspetted into 3 ml phospho-
tungstic acid at given times.
TABLE 1
Inhibition expressed as percentage, control activity
containing corresponding molarity cf NaC1
% Inhi-
bition
NaF 0.1M 75
NaCN 0.1M 2
NaH2PO4 0.2M 70
Rat epiderm. homogenate
acetone powder
extract powder
nil
nil
nil
for solution was 4.9 but there is a shift with
variation in enzyme concentration again making
comparative assays difficult. The pH curve
corresponds to that expected for A or a mixture
of A and B sulfatases and not C no peak being
detected over 2 hrs in Tris buffer pH range
6.7 to 8.0 (6).
Time curves of acetone powder-soluble enzyme
and insoluble residue showed that they were
similar to those expected for sulfatase A solutions
of relatively low activity, the activity being
lower than that required to show the anomalies
exhibited by this enzyme (6). They further gave
no evidence of nitrocatechol metabolism sug-
gesting that the "fall off" found with the acetone
powder was due to absorption on protein.
3. Inhibition
Studies showed that fluoride was a potent
inhibitor of the preparation studied whereas
cyanide was not, suggesting again that sulfatase
present was of the A or B type. Phosphate in
insoluble preparations inhibited less than ex-
pected. This may be due to the powder form or
to the presence of sulfatase C, although pH
properties would be different from those obtained.
In view of reports of enzyme inhibitors present
in normal epidermis (7) rat epidermis was
studied for presence of inhibitors. No evidence for
any sulfatase inhibitor was found (Table 1).
4. Assay Results
From tables 2 and 3 it can clearly be seen that
the per mgm N sulfatase activity is greatly
enhanced in both psoriasis and eczematoid
parakeratoses. Furthermore, in the cases studied,
there was found to be a higher level of sulfatases
in psoriasis than in the other parakeratotic
lesions. Rat epidermis had a higher level of
sulfatase activity than human skin but still
lower than that found for scales; and in this
case the homogenate obtained probably resulted
in a relative overestimation of rat epidermal
activity.
The activity found in psoriasis is remarkably
high compared to most other tissues in the
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TABLE 2
1 sutfatase unit is the amount of enzyme producing
1 g of nitrocetechol per hour under the conditions
above
Disease Activity Per GM Powder(Scales) in Soltatase Units
Psoriasis
Psoriasis
Psoriasis
Psoriasis
Psoriasis
Psoriasis
Eczema
Eczema
Eczema
Eczema
1000
930
1300
1000
800
550
410
214
490
620
TABLE 3
.Tissue Sultatase UnitsPer Mgm N
Psoriasis (scales)
Eczema (scales)
Rat epidermis
Human epidermis
Human callus
5.0
2.2
1.9
0.4
0.0
Sulfatase unit as in table 2.
human body, although very much less than that
found in liver (6).
DTSCUSSION
There is considerable evidence demonstrating
increased esterase levels in parakeratotie horny
layers notably f3-glueuronidase, acid phosphatase,
non specific csterases and lipases (2). It is now
apparent that along with these, arylsulfatase
levels are also increased.
The properties studied show that the enzyme
is of the A or B type, i.e., its properties cor-
respond to the soluble enzyme found in liver
(8) rather than to the insoluble, with the major
portion of the enzyme remaining insoluble. The
pH optimum found suggests that the enzyme is
actually A type with perhaps some B present,
but fluoride inhibition if it is correct to assume
that the enzyme is identical with that of the
liver is suggestive of the presence of the B type.
No concrete evidence for the presence of any of
the C enzyme was found but to this end studies
with p-nitrophenol sulfate should be carried out.
The function of the arylsulfatases is not
known, since natural substrates have not yet
been demonstrated. Still, their increase in para-
keratoses (psoriasis, eczema) is almost certainly a
reflection of the increased metabolism of these
lesions, suggesting they may be concerned with
mucopolysaccharide metabolism. In this con-
nection it is of interest to note that it has been
claimed that in psoriasis there is an increase of
acid mucopolysaecharides (2, 9, 11, 12, 13), in
epidermis and horny layer. It seems therefore that
histochemical correlative studies staining for
mucopolysaceharides and sulfatase would be
of value. The difficulty of drawing any hard and
fast conclusion as to whether the sulfatases then
might be concerned with the synthesis or degrada-
tion of these substances rests in the disagreement
as to be significant of the metachromasia, upon
which staining methods for polymerized muco-
polysaecharides are based.
Although the sulfatase increase seems non-
specific for parakeratoses, in the few patients
studied, the level in psoriasis was significantly
higher than that in other scaling lesions, and
approximately 12 times higher than in normal
skin.
Hence, the role played by the sulfatases in
production of the parakeratotic lesion is, in the
light of present knowledge, difficult to assess.
It seems likely that increase in sulfatase levels
is the result rather than the cause of the lesion.
Although the method is very sensitive and allows
working with very small quantities of material,
its use in differential diagnosis is obviously
limited by the similarity in levels of change in
different types of parakeratoses.
SUMMARy
1. Sulfatase activity of normal and diseased
epidermis was measured.
2. Sulfatase activity was found to be greatly
increased in all parakeratotic lesions (scales)
studied.
3. The major portion of the enzyme was found
to be insoluble, with some properties cor-
responding to the soluble fraction of liver
sulfatases.
4. The significance of increased sulfatase activity
cannot yet be evaluated. Indeed, it is not
unlikely that increased sulfatase levels are
the result—rather than the cause—of para-
keratosis.
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ANNOUNCEMENT
Dr. V. J. McGovern of Sydney, Australia read his prize winning essay on "The
Mechanism of Photosensitivity: An Experimental Study" at the Eightieth An-
nual Meeting of the American Dermatologieal Association, Inc. held at the Boea
Raton Hotel and Club, Boea Raton, Florida. Dr. McGovern is director of the
Fairfax Institute of Pathology in the Royal Prince Alfred Hospital at Sydney,
Australia.
Papers for the Eleventh Annual Essay Contest should be submitted to the
Secretary of the American Dermatological Association Research and Educa-
tional Fund, Inc., Dr. Wiley M. Sams, 308 Ingraham Building; Miami 32, Florida
not later than November 1, 1960.
